Skip to content

Therapeutic effects of rhubarb enema on Th17 cell and systemic inflammatory response in patients with acute pancreatitis

Therapeutic effects of rhubarb enema on Th17 cell and systemic inflammatory response in patients with acute pancreatitis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046548
Enrollment
Unknown
Registered
2021-05-21
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Interventions

Sponsors

The First Affiliated Hospital of Chongiqng Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with acute pancreatitis who were hospitalized in the ICU (Intensive Care Unit) of the First Affiliated Hospital of Chongqing Medical University; 2. The diagnosis of acute pancreatitis is based on the 2012 Atlanta revised diagnostic criteria: (1) Pancreatic pain that is acute and radiates to the lower back; (2) Serum amylase and lipase levels are more than 3 times higher than normal levels; (3) In line with the imaging examination of acute pancreatitis. Patients who meet the diagnosis include at least two of the above characteristics. 3. The patient voluntarily signed the informed consent form; 4. Aged 18 to 80 years.

Exclusion criteria

Exclusion criteria: 1. Any surgery performed three days after admission; 2. Past or current use of immunosuppressive agents; 3. Impaired innate immune function; 4. History of tumor or chronic lung disease, kidney disease or cardiovascular disease; 5. Biliary pancreatitis or traumatic pancreatitis; 6. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Th17 / CD4 + Ratio;Serum levels of tumor necrosis factor-a (TNF-a), interleukin-1ß (IL-1ß), interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-10 (IL-10), interleukin-17A (IL-17A) and CXCL1;

Countries

China

Contacts

Public ContactYang Jian

The First Affiliated Hospital of Chongiqng Medical University

yj1984ren@qq.com+86 23 89012021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026